These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 31888545)
1. Elucidating the expression and function of Numbl during cell adhesion-mediated drug resistance (CAM-DR) in multiple myeloma (MM). Huang Y; Huang X; Cheng C; Xu X; Liu H; Yang X; Yao L; Ding Z; Tang J; He S; Wang Y BMC Cancer; 2019 Dec; 19(1):1269. PubMed ID: 31888545 [TBL] [Abstract][Full Text] [Related]
2. Wnt3/RhoA/ROCK signaling pathway is involved in adhesion-mediated drug resistance of multiple myeloma in an autocrine mechanism. Kobune M; Chiba H; Kato J; Kato K; Nakamura K; Kawano Y; Takada K; Takimoto R; Takayama T; Hamada H; Niitsu Y Mol Cancer Ther; 2007 Jun; 6(6):1774-84. PubMed ID: 17575106 [TBL] [Abstract][Full Text] [Related]
3. Bortezomib overcomes cell-adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma. Noborio-Hatano K; Kikuchi J; Takatoku M; Shimizu R; Wada T; Ueda M; Nobuyoshi M; Oh I; Sato K; Suzuki T; Ozaki K; Mori M; Nagai T; Muroi K; Kano Y; Furukawa Y; Ozawa K Oncogene; 2009 Jan; 28(2):231-42. PubMed ID: 18850009 [TBL] [Abstract][Full Text] [Related]
5. The role of ubiquitin-specific protease 14 (USP14) in cell adhesion-mediated drug resistance (CAM-DR) of multiple myeloma cells. Xu X; Liu J; Shen C; Ding L; Zhong F; Ouyang Y; Wang Y; He S Eur J Haematol; 2017 Jan; 98(1):4-12. PubMed ID: 26710889 [TBL] [Abstract][Full Text] [Related]
6. The Impact of Integrin-Mediated Matrix Adhesion on Cisplatin Resistance of W1 Ovarian Cancer Cells. Wantoch von Rekowski K; König P; Henze S; Schlesinger M; Zawierucha P; Januchowski R; Bendas G Biomolecules; 2019 Nov; 9(12):. PubMed ID: 31779287 [TBL] [Abstract][Full Text] [Related]
7. The HMG-CoA reductase inhibitor simvastatin overcomes cell adhesion-mediated drug resistance in multiple myeloma by geranylgeranylation of Rho protein and activation of Rho kinase. Schmidmaier R; Baumann P; Simsek M; Dayyani F; Emmerich B; Meinhardt G Blood; 2004 Sep; 104(6):1825-32. PubMed ID: 15161667 [TBL] [Abstract][Full Text] [Related]
8. Expression of vaccinia-related kinase 1 (VRK1) accelerates cell proliferation but overcomes cell adhesion mediated drug resistance (CAM-DR) in multiple myeloma. Liu J; Wang Y; He S; Xu X; Huang Y; Tang J; Wu Y; Miao X; He Y; Wang Q; Liang L; Cheng C Hematology; 2016 Dec; 21(10):603-612. PubMed ID: 27319807 [TBL] [Abstract][Full Text] [Related]
9. ADP-ribosylation factor 1 (ARF1) takes part in cell proliferation and cell adhesion-mediated drug resistance (CAM-DR). Xu X; Wang Q; He Y; Ding L; Zhong F; Ou Y; Shen Y; Liu H; He S Ann Hematol; 2017 May; 96(5):847-858. PubMed ID: 28238095 [TBL] [Abstract][Full Text] [Related]
10. Adhesion to fibronectin induces p27(Kip1) nuclear accumulation through down-regulation of Jab1 and contributes to cell adhesion-mediated drug resistance (CAM-DR) in RPMI 8,226 cells. Fei M; Hang Q; Hou S; He S; Ruan C Mol Cell Biochem; 2014 Jan; 386(1-2):177-87. PubMed ID: 24170542 [TBL] [Abstract][Full Text] [Related]
11. Pyruvate kinase isoform M2 (PKM2) participates in multiple myeloma cell proliferation, adhesion and chemoresistance. He Y; Wang Y; Liu H; Xu X; He S; Tang J; Huang Y; Miao X; Wu Y; Wang Q; Cheng C Leuk Res; 2015 Dec; 39(12):1428-36. PubMed ID: 26453405 [TBL] [Abstract][Full Text] [Related]
12. Beta1 integrin adhesion enhances IL-6-mediated STAT3 signaling in myeloma cells: implications for microenvironment influence on tumor survival and proliferation. Shain KH; Yarde DN; Meads MB; Huang M; Jove R; Hazlehurst LA; Dalton WS Cancer Res; 2009 Feb; 69(3):1009-15. PubMed ID: 19155309 [TBL] [Abstract][Full Text] [Related]
13. Adhesion to fibronectin via beta1 integrins regulates p27kip1 levels and contributes to cell adhesion mediated drug resistance (CAM-DR). Hazlehurst LA; Damiano JS; Buyuksal I; Pledger WJ; Dalton WS Oncogene; 2000 Sep; 19(38):4319-27. PubMed ID: 10980607 [TBL] [Abstract][Full Text] [Related]
14. Cell adhesion induces overexpression of chromodomain helicase/ATPase DNA binding protein 1-like gene (CHD1L) and contributes to cell adhesion-mediated drug resistance (CAM-DR) in multiple myeloma cells. Xu X; He Y; Miao X; Wu Y; Han J; Wang Q; Liu J; Zhong F; Ou Y; Wang Y; He S Leuk Res; 2016 Aug; 47():54-62. PubMed ID: 27258734 [TBL] [Abstract][Full Text] [Related]
15. Cell adhesion mediated drug resistance (CAM-DR): role of integrins and resistance to apoptosis in human myeloma cell lines. Damiano JS; Cress AE; Hazlehurst LA; Shtil AA; Dalton WS Blood; 1999 Mar; 93(5):1658-67. PubMed ID: 10029595 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of ADAM12 contributes to accelerated cell proliferation and cell adhesion-mediated drug resistance (CAM-DR) in Non-Hodgkin's Lymphoma. Yin H; Zhong F; Ouyang Y; Wang Q; Ding L; He S Hematology; 2017 Oct; 22(9):527-535. PubMed ID: 28395594 [TBL] [Abstract][Full Text] [Related]
17. PI3K/Akt inhibitor LY294002 potentiates homoharringtonine antimyeloma activity in myeloma cells adhered to stromal cells and in SCID mouse xenograft. Chen P; Wen X; Wang B; Hou D; Zou H; Yuan Q; Yang H; Xie J; Huang H Ann Hematol; 2018 May; 97(5):865-875. PubMed ID: 29450644 [TBL] [Abstract][Full Text] [Related]
18. Cell adhesion to fibronectin down-regulates the expression of Spy1 and contributes to drug resistance in multiple myeloma cells. Fei M; Hang Q; Hou S; Ruan C Int J Hematol; 2013 Oct; 98(4):446-55. PubMed ID: 24037419 [TBL] [Abstract][Full Text] [Related]
19. Overexpression of fibronectin confers cell adhesion-mediated drug resistance (CAM-DR) against 5-FU in oral squamous cell carcinoma cells. Nakagawa Y; Nakayama H; Nagata M; Yoshida R; Kawahara K; Hirosue A; Tanaka T; Yuno A; Matsuoka Y; Kojima T; Yoshitake Y; Hiraki A; Shinohara M Int J Oncol; 2014 Apr; 44(4):1376-84. PubMed ID: 24452447 [TBL] [Abstract][Full Text] [Related]
20. Acquisition of resistance toward HYD1 correlates with a reduction in cleaved α4 integrin expression and a compromised CAM-DR phenotype. Emmons MF; Gebhard AW; Nair RR; Baz R; McLaughlin ML; Cress AE; Hazlehurst LA Mol Cancer Ther; 2011 Dec; 10(12):2257-66. PubMed ID: 21980133 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]